Role of zonisamide in advanced Parkinson’s disease: a randomized placebo-controlled study

被引：0
|
作者：
Mohamed Essam
Eman Hamid
Eman Abushady
Mahmoud El-Balkimy
Angelo Antonini
Ali Shalash
机构：
[1] Ain Shams University,Department of Neurology, Faculty of Medicine
[2] University of Padua,Parkinson and Movement Disorders Unit, Study Center for Neurodegeneration (CESNE), Department of Neuroscience
来源：
Neurological Sciences | 2024年 / 45卷
关键词：
Zonisamide; Parkinson̕ s disease; Wearing off; Nonmotor symptoms; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1725 / 1734
页数：9
相关论文
共 50 条
  • [41] Randomized, double-blind, placebo-controlled study of naltrexone for impulse control disorders in Parkinson's disease
    Weintraub, D.
    Xie, S. X.
    Stern, M.
    Hurtig, H.
    Siderowf, A.
    Minger, J.
    Papay, K.
    MOVEMENT DISORDERS, 2013, 28 : S141 - S142
  • [42] Mucuna pruriens therapy in Parkinson's disease: A double-blind, placebo-controlled, randomized, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    MOVEMENT DISORDERS, 2015, 30 : S425 - S425
  • [43] Creatine supplementation in Parkinson disease:: A placebo-controlled randomized pilot trial
    Bender, A.
    Koch, W.
    Elstner, M.
    Schombacher, Y.
    Bender, J.
    Moeschl, M.
    Gekeler, F.
    Mueller-Myhsok, B.
    Gasser, T.
    Tatsch, K.
    Klopstock, T.
    NEUROLOGY, 2006, 67 (07) : 1262 - 1264
  • [44] Randomized, placebo-controlled study investigating the safety, pharmacokinetics and efficacy of inhaled apomorphine in Parkinson's disease patients
    Thijssen, E.
    den Heijer, J.
    Puibert, D.
    Lei, M.
    Hasegawa, D.
    Keum, K.
    Mochel, K.
    Roset, P.
    van Brummelen, E.
    Naranda, T.
    Groeneveld, G.
    MOVEMENT DISORDERS, 2020, 35 : S428 - S428
  • [45] Design of a randomized, placebo-controlled trial of pramipexole in patients with Parkinson's disease and depressive symptoms
    Barone, P.
    Schapira, A. H. V.
    Debieuvre, C. D.
    Massey, D.
    MOVEMENT DISORDERS, 2008, 23 (01) : S199 - S199
  • [46] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [47] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [48] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [49] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
  • [50] A Pilot Randomized Placebo-Controlled Trial of Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
    Altman, Robert
    Lang, Anthony
    Munhoz, Renato
    Charand, Katia
    Wadup, Lisa
    Postuma, Ronald
    NEUROLOGY, 2011, 76 (09) : A275 - A275
12345